Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...